BACKGROUND: The systemic immune-inflammation index (SII), integrated by peripheral lymphocyte, neutrophil, and platelet counts, is used as an objective biomarker that reflects the balance between host inflammatory and immune response status in cancer patients. Herein, we examined the prognostic significance of SII in gastric cancer patients. METHODS: We retrospectively reviewed data of 415 patients who underwent curative laparoscopic gastrectomy using propensity score-matched (PSM) analysis. The prognostic value of SII was compared between two groups based on SII values: low SII group (SII < 661.9) and high SII group (SII ≥ 661.9). RESULTS: In multivariate analysis, the American Society of Anesthesiologists physical status (ASA-PS) (p < 0.001), tumor differentiation (p = 0.019), pathological stage (p = 0.046), carcinoembryonic antigen (CEA) level (p < 0.001), SII (p = 0.006), and operative procedure (p = 0.009) were independent prognostic factors of overall survival (OS) in the overall PSM cohort. The log-rank test demonstrated that patients with a high SII had significantly worse OS than did those with low SII (p = 0.002). In age-stratified subgroups analysis (< 65/≥ 65 years), multivariate analysis revealed that ASA-PS (p < 0.001), tumor differentiation (p = 0.019), CEA level (p = 0.008), SII (p = 0.013), and operative procedure (p = 0.026) were independent prognostic factors of OS in the elderly group. Similarly, elderly patients with a high SII had significantly worse OS than did those with a low SII (p = 0.009). Meanwhile, SII was not an independent prognostic factor of OS, and no significant association was observed between SII and OS in non-elderly patients. CONCLUSIONS: SII was an independent prognostic indicator in gastric cancer patients, especially in the elderly population.
BACKGROUND: The systemic immune-inflammation index (SII), integrated by peripheral lymphocyte, neutrophil, and platelet counts, is used as an objective biomarker that reflects the balance between host inflammatory and immune response status in cancerpatients. Herein, we examined the prognostic significance of SII in gastric cancerpatients. METHODS: We retrospectively reviewed data of 415 patients who underwent curative laparoscopic gastrectomy using propensity score-matched (PSM) analysis. The prognostic value of SII was compared between two groups based on SII values: low SII group (SII < 661.9) and high SII group (SII ≥ 661.9). RESULTS: In multivariate analysis, the American Society of Anesthesiologists physical status (ASA-PS) (p < 0.001), tumor differentiation (p = 0.019), pathological stage (p = 0.046), carcinoembryonic antigen (CEA) level (p < 0.001), SII (p = 0.006), and operative procedure (p = 0.009) were independent prognostic factors of overall survival (OS) in the overall PSM cohort. The log-rank test demonstrated that patients with a high SII had significantly worse OS than did those with low SII (p = 0.002). In age-stratified subgroups analysis (< 65/≥ 65 years), multivariate analysis revealed that ASA-PS (p < 0.001), tumor differentiation (p = 0.019), CEA level (p = 0.008), SII (p = 0.013), and operative procedure (p = 0.026) were independent prognostic factors of OS in the elderly group. Similarly, elderly patients with a high SII had significantly worse OS than did those with a low SII (p = 0.009). Meanwhile, SII was not an independent prognostic factor of OS, and no significant association was observed between SII and OS in non-elderly patients. CONCLUSIONS: SII was an independent prognostic indicator in gastric cancerpatients, especially in the elderly population.
Entities:
Keywords:
Gastric cancer; Overall survival; Systemic immune-inflammation index
Authors: Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi Journal: Ann Surg Date: 2009-08 Impact factor: 12.969
Authors: Aurélien Dupré; Robert P Jones; Rafael Diaz-Nieto; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik Journal: World J Surg Date: 2019-05 Impact factor: 3.352
Authors: Junya Toyoda; Kota Sahara; Shishir K Maithel; Daniel E Abbott; George A Poultsides; Christopher Wolfgang; Ryan C Fields; Jin He; Charles Scoggins; Kamran Idrees; Perry Shen; Itaru Endo; Timothy M Pawlik Journal: Ann Surg Oncol Date: 2022-06-29 Impact factor: 4.339
Authors: Dominik Safcak; Sylvia Drazilova; Jakub Gazda; Igor Andrasina; Svetlana Adamcova-Selcanova; Lea Balazova; Radovan Barila; Michal Mego; Marek Rac; Lubomir Skladany; Miroslav Zigrai; Martin Janicko; Peter Jarcuska Journal: J Clin Med Date: 2022-07-19 Impact factor: 4.964